- Q1 2024 Kura Oncology Inc Earnings Call TranscriptMay 02, 2024€18.75 (+1.13%)Earnings
- Q4 2023 Kura Oncology Inc Earnings Call TranscriptFeb 27, 2024€19 (+2.15%)Earnings
- Kura Oncology Inc To Discuss Preliminary Combo Data Call TranscriptJan 30, 2024
- Q3 2023 Kura Oncology Inc Earnings Call TranscriptNov 02, 2023€7.5 (-5.66%)Earnings
- Q2 2023 Kura Oncology Inc Earnings Call TranscriptAug 03, 2023€9.35 (+0.54%)Earnings
- Kura Oncology Inc Investor Day TranscriptJun 12, 2023
- Kura Oncology Inc at TD Cowen Oncology Innovation Summit (Virtual) TranscriptMay 30, 2023
- Kura Oncology Inc at JMP Securities Life Sciences Conference TranscriptMay 16, 2023
- Q1 2023 Kura Oncology Inc Earnings Call TranscriptMay 10, 2023€10.4 (+2.97%)Earnings
- Kura Oncology Inc at Stifel Targeted Oncology Days (Virtual) TranscriptApr 25, 2023
- Kura Oncology Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Kura Oncology Inc Earnings Call TranscriptFeb 23, 2023€11.2 (+1.82%)Earnings
- Kura Oncology Inc ASH Investor Event Call TranscriptDec 10, 2022
- Kura Oncology Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Kura Oncology Inc Earnings Call TranscriptNov 03, 2022€15.8 (-1.25%)Earnings
- Q2 2022 Kura Oncology Inc Earnings Call TranscriptAug 03, 2022€14.6 (+1.39%)Earnings
- Kura Oncology Inc at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Kura Oncology Inc at Cowen Oncology Innovation Summit: Insights for ASCO & EHA (Virtual) TranscriptJun 02, 2022
- Q1 2022 Kura Oncology Inc Earnings Call TranscriptMay 04, 2022€14.1 (-0.70%)Earnings
- Kura Oncology Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Q4 2021 Kura Oncology Inc Earnings Call TranscriptFeb 24, 2022€12.2 (-3.17%)Earnings
- Kura Oncology Inc at Clinical Update Call TranscriptNov 24, 2021
- Kura Oncology Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2021
- Q3 2021 Kura Oncology Inc Earnings Call TranscriptNov 04, 2021€15.7 (+6.80%)Earnings
- Kura Oncology Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- Q2 2021 Kura Oncology Inc Earnings Call TranscriptAug 05, 2021€14.8 (-2.63%)Earnings
- Q1 2021 Kura Oncology Inc Earnings Call TranscriptMay 06, 2021€21.2Earnings
- Kura Oncology Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Kura Oncology Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Kura Oncology Inc Earnings Call TranscriptFeb 24, 2021€27.2 (+0.74%)Earnings
- Kura Oncology Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Kura Oncology Inc ASH Virtual Investor Event TranscriptDec 05, 2020
- Kura Oncology Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2020
- Q3 2020 Kura Oncology Inc Earnings Call TranscriptNov 05, 2020€28.2 (-2.08%)Earnings
- Q2 2020 Kura Oncology Inc Earnings Call TranscriptAug 06, 2020€14.7 (+2.08%)Earnings
- Kura Oncology Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Kura Oncology Inc Earnings Call TranscriptMay 04, 2020€13.4 (-6.29%)Earnings
- Q4 2019 Kura Oncology Inc Earnings Call TranscriptFeb 25, 2020€11.5 (+1.77%)Earnings
- Kura Oncology Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 Kura Oncology Inc Earnings Call TranscriptNov 05, 2019€13.6 (+0.74%)Earnings
- Kura Oncology Inc at Citi Biotech Conference TranscriptSep 05, 2019
- Q2 2019 Kura Oncology Inc Earnings Call TranscriptAug 01, 2019€17.11 (+0.29%)Earnings
- Kura Oncology Inc EHA Data Review Conference Call TranscriptJun 14, 2019
- Kura Oncology Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Kura Oncology Inc Earnings Call TranscriptMay 07, 2019€13.96 (+3.03%)Earnings
- Q4 2018 Kura Oncology Inc Earnings Call TranscriptMar 05, 2019€13.13 (-1.50%)Earnings
Kura Oncology Inc at Citi Biotech Conference Transcript
Session 2, focusing the laser on precision oncology. We had some companies yesterday on this theme, so this is our sequel. So it's my pleasure to introduce the Chief Executive Officers of Epizyme, Robert Bazemore; sitting over in the middle, from Kura, Troy Wilson, President and CEO; and to my right, Ali Tehrani, the CEO of Zymeworks.
So welcome all of you, thanks for taking the time. And just to start out, I think it would be helpful if each of you could give a quick 2- to 3-minute overview of your pipeline, your strategy, what are the key objectives for each of your companies.
Ali, you want to kick it off?
Sure. Thank you very much for organizing this conference and having us here. Zymeworks has focused on the research and development of multifunctional biologics. Currently, we have a number of bispecific antibodies in the clinic, our lead product is ZW25, which is a biparatopic antibody focused on HER2
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)